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INTRODUCTION
Gene regulatory programs are key drivers of cellular state change. The most common class of such programs are transcriptional, in which one or a few transcription factors (TFs) are activated in response to an environmental or developmental cue to induce expression of genes whose protein products are required to promote the transition to a new cell state. It seems likely that such cellular transitions should also require downregulation of gene sets, either because specific proteins impede the cell's transition to a new cellular state or simply for the cell to free up capacity for the production of proteins needed for the transition. The mechanisms by which such downregulation is achieved have been less well studied than those that drive upregulation, although some such mechanisms are known, including those involving protein degradation and transcriptional repressor proteins. With few exceptions (e.g., Haghighat et al., 1996; Hinnebusch, 1993; Hollien et al., 2009) , however, our understanding of the gene regulatory programs underlying cellular state change has lacked a coherent explanation for how up-and downregulation are coordinated.
A recently defined mode of gene regulation is an attractive candidate for broadly mediating such coordination ( Figure 1A ). This mechanism was shown to harness TF-driven synthesis of an open reading frame (ORF)-encoding transcript to repress synthesis of the kinetochore protein Ndc80, a key event during meiotic differentiation in budding yeast Chia et al., 2017) . In short, it was found that NDC80 has two transcription start sites (TSSs) that are activated by different TFs. Activation of the proximal TSS produces a canonical transcript that is translated to produce protein. Activation of the distal TSS results in synthesis of a 5 0 extended transcript that encodes the NDC80 ORF, but does not lead to ORF expression because of translation of upstream ORFs (uORFs) in the extended 5 0 leader. Use of the distal TSS also represses use of the proximal TSS in cis by transcriptional interference. Effectively, as a result of this integrated mechanism, synthesis of the longer transcript halts Ndc80 protein production. This longer mRNA was termed a LUTI (long undecoded transcript isoform) Chia et al., 2017) .
Subsets of the hallmarks of LUTI-based regulation defined above were previously observed for several other genes (Law et al., 2005; Moseley et al., 2002; Sehgal et al., 2008) , suggesting that use of this mechanism might be widespread. We recently found that LUTI-based regulation is common and responsible for setting protein levels of at least 380 genes as yeast cells progress through meiotic differentiation . We showed that this mechanism enables a single meiotic TF to regulate two distinct sets of targets in a highly coordinated manner. The canonical set includes ''positive'' targets, whose transcription results in increased protein production, and ''negative'' LUTI targets, whose transcription leads to decreased protein production. While both sets of targets may exhibit increases in mRNA production, for genes that are regulated by the LUTIbased mechanism, overall mRNA levels are decoupled from protein levels. In fact, the 380 meiotic LUTI targets that we defined were found based on the signature of a poor, or even negative, correlation between mRNA and protein levels over time Otto and Brar, 2018) . For these cases, it is the type of transcript produced rather than the amount that determines whether protein is synthesized. Given the pervasiveness of LUTI-based regulation during meiosis, it seemed possible that this mechanism might generally be used to coordinate gene up-and downregulation during cellular transitions. We sought a well-defined cellular state change in which to test this hypothesis. We chose to focus on the branch of the ER unfolded protein response (UPR ER ) that is conserved from budding yeast to human and relies on the Hac1 TF (orthologous to Xbp1 in metazoans) to allow cells to respond to aberrant protein folding within the ER lumen (reviewed in Han and Kaufman, 2017; Walter and Ron, 2011) . The UPR ER is typically experimentally induced by treatment of cells with drugs that disrupt ER folding, such as DTT or tunicamycin (Tm). The resulting accumulation of misfolded proteins in the ER lumen promotes activation of the ER membrane-spanning kinase Ire1, which subsequently removes a translationally repressive cytoplasmically retained intron from the HAC1 transcript through an atypical splicing event Mori et al., 1996; Sidrauski et al., 1996) . Spliced HAC1 mRNA can be efficiently translated to produce a TF that activates a set of target genes, the most well-studied of which play clear roles in increasing ER volume, folding capacity, and quality control. Included in this set of canonical Hac1 targets are chaperones, such as BiP (KAR2 in yeast), protein disulfide isomerase (PDI1 in yeast), and lumenal Hsp70 (LHS1), as well as genes responsible for ER structure, lipid synthesis, and ER redox balance, such as thiol oxidase (ERO1; reviewed in Chapman et al., 1998 ). An ORF microarray study identified $400 mRNAs that were induced in response to UPR ER activation in a Hac1-dependent manner, some of which were known to have clear function in ER biology, but many of which were not and whose function in the UPR ER remains mysterious . Given that mRNA sequence levels can be misleading predictors of gene expression output, we hypothesized that some of the previously identified Hac1 transcriptional targets might actually be negatively regulated at the protein level via a LUTI-based mechanism. If this were true, it might help to explain why many of the genes that are transcriptionally induced by the UPR ER do not result in protein misfolding in the ER when deleted and why-with few exceptions-roles in the UPR ER remain undefined for most (Jonikas et al., 2009; Schuldiner and Weissman, 2013; Travers et al., 2000) . 
RESULTS

Hac1 Induces Expression of LUTI Targets, Resulting in Protein Downregulation
To determine whether Hac1 induces LUTI-like repressive transcripts as part of the UPR ER , we performed global gene expression measurements in WT and hac1D cells. We performed parallel mRNA sequencing (mRNA-seq) and ribosome profiling on untreated samples and those treated for 1 hr with either DTT or Tm to assay mRNA abundance and translation in response to UPR ER activation ( Figure 1B were also generally induced at the mRNA level in our dataset, dependent on Hac1 ( Figures 1C-1E ).
The most strongly upregulated transcripts included characterized UPR ER targets KAR2, ULI1, PDI1, and ERO1 (Figures 1C-1E ; Chapman et al., 1998; Metzger and Michaelis, 2008) . When we evaluated translation levels (based on ribosome footprint . Reported Hac1 targets were significantly (****p < 0.0001) more likely to be upregulated in a Hac1-dependent manner upon UPR ER induction than the full gene set.
(F-H) Comparison of TEs for each gene with and without activation of an intact UPR ER . For (C) to (H), previously reported Hac1 targets are shown as dark squares while all other genes are shown as light circles. See also Figure S1 ; Tables S1 and S2 . (legend on next page) density), we saw prominent induction of the best-characterized Hac1 targets, as expected (Figures S1A-S1E). Overall, we identified 477 genes as showing a UPR ER -and Hac1-dependent increase in translation of greater than 2-fold in this dataset. Genes in this group were strongly enriched for ER-localization and function, as expected (p value for ER = 2.64 3 10 À14 ; post-translational protein targeting to membrane, translocation = 1.33 3 10 À6 ; protein glycosylation = 1.58 3 10 À5 ; note that this set is based on analysis of DTT data, but Tm treatment yields similar results; Tables S1 and S2 ; Figures S1A-S1D).
Normalizing translation levels to mRNA levels allowed us to determine TEs across all annotated ORFs (Ingolia et al., 2009) , enabling detection of Hac1-dependent TE shifts upon UPR ER activation. Although UPR ER activation has been reported to influence TEs of some genes (Krishnan et al., 2014; Labunskyy et al., 2014; Payne et al., 2008) , little is known about the pervasiveness of or potential mechanisms behind such regulation. Rather, the UPR ER has been defined primarily as a transcriptional response. Our data are consistent with this general model, with a clear cohort of UPR ER -driven, Hac1-dependent upregulated transcripts seen ( Figures 1C-1E ). However, evidence for several dozen translationally regulated genes also emerged from our data. As expected, HAC1 was one of the most strongly translationally upregulated genes upon DTT or Tm treatment ( Figures  1F and 1G ). An additional small subset of annotated Hac1 transcriptional targets seemed to show translational upregulation with UPR ER activation, although the mechanistic basis for this remains unclear. The most prominent example was functionally uncharacterized ER-related gene ULI1 (Metzger and Michaelis, 2008) , which was also one of the most highly induced transcriptional targets of Hac1 ( Figure 1E ). The large increase in ULI1 TE seen upon DTT treatment may point to a new translational mechanism linked to UPR ER activation ( Figures 1F-1H ).
Additionally, several annotated Hac1 targets appeared to show a Hac1-dependent decrease in TE upon UPR ER activation ( Figures 1F-1H ). This type of TF-dependent TE drop is a hallmark of LUTI-based regulation during meiotic differentiation . Because transcription of poorly translated LUTI mRNAs decreases production of canonical welltranslated transcript isoforms, TF-driven LUTI mRNA synthesis is detected in ribosome profiling datasets as translational repression . We focused our attention on investigating HNT1, an annotated Hac1 target that consistently showed strong Hac1-and UPR ER -dependent translational repression (Figures 1F-1H ; Travers et al., 2000) by comparing its regulation with that of the most well-characterized Hac1 target, KAR2. HNT1 is a conserved member of the histidine triad superfamily (Sé raphin, 1992) . Its cellular function remains unclear, although a mammalian family member has recently been implicated in regulation of m 7 G mRNA caps, suggesting that this gene family may be involved in translation (Kiss et al., 2017a (Kiss et al., , 2017b . Before investigating HNT1 regulation, we first confirmed that our dataset reported the expected mRNA induction of canonical UPR ER targets. As expected, a single KAR2 mRNA isoform accumulated in a UPR ER -and Hac1-dependent manner, as judged by northern blotting (Figures 2A and S2A) . KAR2 mRNA was well-translated when present, with little change in TE seen upon UPR ER activation ( Figure 2B ). In contrast, while UPR ER activation resulted in increased overall HNT1 mRNA levels ( Figure S3B ), it also resulted in a shift in the transcript isoforms present in cells. A longer HNT1 mRNA species was observed by mRNA-seq and northern blotting following 1 hr of DTT or Tm treatment ( Figures 2C, 2D , S2B, and S3C Figure S3A ), production of the long HNT1 transcript isoform was dependent on IRE1, and thus part of the canonical UPR ER ( Figure S3C ).
We identified a strong type-2 UPR element (UPRE2), a DNA motif associated with Hac1 binding in the promoters of some UPR ER targets (Patil et al., 2004) , close to the distal HNT1 TSS ( Figure 2C ). The location of the UPRE2, coupled with the observation that induction of the longer transcript was dependent on HAC1, led us to hypothesize that the long HNT1 isoform was a direct Hac1 target. To test this hypothesis, we constructed reporters containing GFP under control of the extended promoter region of HNT1, with either an intact UPRE2 adjacent to the distal TSS or a mutated motif ( Figure 2K ). Following 90 min of DTT treatment, cells harboring pHNT1-GFP produced a high level of an extended GFP transcript isoform whose expression was severely reduced in the pHNT1DUPRE2-GFP mutant ( Figures 2L, S2C , and S3D). GFP protein levels in the WT reporter, but not the UPRE2 mutant, mirrored those of Hnt1 following UPR ER induction ( Figures 2M  and 2N ). We concluded that HNT1 is a LUTI target of Hac1 and that the UPR ER involves coordinated activation and repression of target gene expression through Hac1-regulated alternative TSS usage. We suspected that HNT1 might be just one of a class of ''negative'' targets of Hac1 and thus performed a systematic analysis of our data, searching for the expected signatures of Hac1 LUTI targets, including Hac1-dependent decreases in TE and appearances of 5 0 extended transcripts . While this has been a valuable approach, the risk in comparing gene expression measurements from WT cells and constitutive mutants is that it is difficult to ensure that secondary effects-on gene expression and in the form of genetic suppressors-are not confounding, resulting in misinterpretation of results. Such suppressors have been reported in hac1D cells, including in our strain background (Lee et al., 2003) . We were concerned that perhaps our identification of non-canonical Hac1 targets might be an unexpected artifact of such secondary effects. We therefore replaced Hac1 with a version that contained an auxin-inducible degron (AID) tag and thus could be depleted on-demand by auxin addition. We found that AID-HAC1 rescued the growth defect of hac1D cells grown with DTT, suggesting normal functionality (Figures 3A and 3B; Nishimura et al., 2009) . AID-Hac1 was stable in the presence of auxin in strains lacking the exogenous plant TIR1 F-box auxin receptor gene, but in strains carrying TIR1, AID-Hac1 that 
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Systematic analysis of mRNA-seq and TE data from WT and hac1D cells ( Figure 1B ) was used to predict LUTI candidates. Nineteen candidates were identified. Reanalysis of these same features using the AID-HAC1 allele ( Figure 4A ) confirmed 15 of these candidates, and many were previously reported to show decreased translation upon Tm addition (Labunskyy et al., 2014 accumulated during DTT pre-treatment was rapidly depleted upon auxin addition ( Figures 3C and 3D ). Notably, AID-Hac1 protein was efficiently, but not fully, depleted in this background.
As a result, we expected gene expression effects measured by comparing AID-HAC1 TIR1 cells with and without auxin to be dampened relative to those from comparison of WT and hac1D cells. Given that auxin-mediated degradation should be cytoplasmic, we were concerned that a persisting nuclear pool of AID-Hac1 may be capable of robustly carrying out its TF function, spatially isolated from the location of degradation. To investigate this, we analyzed expression of KAR2 in cells that were treated with auxin following 45 min of DTT pre-treatment. KAR2 levels were rapidly reduced under these conditions, suggesting that auxin-induced Hac1 degradation reduced its TF activity (Figures 3E and S2D) . This result indicated that kinetic experiments using AID-HAC1 cells might allow confident prediction of direct Hac1 transcriptional targets. The long isoform of HNT1 (HNT1 LUTI ) showed dynamics similar to that of the KAR2 transcript, declining to undetectable levels within 20 min of auxin treatment following DTT pre-treatment (Figures 3F and S2E) . This rapid timing provided additional evidence that HNT1 LUTI is a direct target of Hac1. Although robust changes to transcription were observed by this strategy, effects on protein level of the canonical target Kar2 were not readily reversible upon auxin addition (data not shown), perhaps because Kar2 protein is not rapidly turned over under these circumstances. Because we have found assaying protein level to be useful in determining whether a given transcriptional target is positive or negative , we reasoned that pre-treating cells with auxin and subsequently inducing the UPR ER would be a more fruitful strategy. To this end, we pre-treated cells with auxin for 15 min and then added DTT for up to 2 hr. In cells lacking TIR1, KAR2 mRNA and protein levels revealed the expected induction upon DTT treatment regardless of auxin addition . In contrast, in the TIR1 background, DTT-dependent increases in KAR2 transcript and protein levels were only observed if cells were pretreated with vehicle. When pre-treated with auxin (depleting Hac1), efficient KAR2 induction was largely prevented . We next performed a new set of global gene expression measurements using the AID-HAC1 strain background ( Figure 4A ). We again measured mRNA and translation levels, and additionally collected matched extract for mass spectrometry in order to more completely evaluate Hac1-dependent effects on cellular physiology during the UPR ER . Global effects on mRNA and translation were similar to those observed in our previous WT/hac1D experiment (Figures 4B, 4C, and S4) were not an artifact of constitutive HAC1 deletion ( Figure 2 ).
Hac1 ''Negative'' Targets Include Genes Involved in ETC Function
We found that 15 of the original 19 annotated long transcript isoforms could be confirmed as UPR ER -and Hac1-dependent in the AID-HAC1 background (Table 1 ). Of the four that could not, two did not show the expected TE decrease and two showed the decrease independent of Hac1. These cases may be a result of yet undefined secondary effects in the delete background. We concluded that a set of LUTI targets is induced by Hac1 as part of the UPR ER .
Several of the 15 Hac1-dependent LUTI-regulated genes were involved in electron transport chain (ETC) function, specifically in assembly of complex IV (cytochrome c oxidase), to which LUTI targets COX20, OXA1, and SOM1 all contribute. We thus investigated the possibility that downregulation of ETC components might be linked to UPR ER activation and partly controlled by LUTI-based regulation. We first examined the regulation of COX20, a gene responsible for Cox2 processing and subsequent assembly of complex IV (Hell et al., 2000) . We confirmed the Hac1-dependent appearance of a dramatically 5 0 extended transcript isoform upon UPR ER activation by mRNA-seq (Figure 5A ) and translation of a uORF near the 5 0 end of this extended transcript, which was adjacent to a high-scoring UPRE2 (Figure S5B) . Northern blotting for COX20 revealed Hac1-dependent induction of a longer transcript upon DTT or Tm treatment, confirming that the mRNA-seq data did not simply reflect a partially overlapping transcript that excluded the COX20 ORF (Figures (legend continued on next page) 5B, 5C, S2H, S2I, and S5A). This longer COX20 transcript isoform was also dependent on IRE1 ( Figure S5D ). We were initially concerned that the bands representing the two COX20 transcript isoforms did not show the stoichiometry expected based on our mRNA-seq data from either large-scale experiment, with the longer transcript reproducibly resulting in a much fainter band than the canonical transcript. We attribute this effect to the large size difference between the transcripts (0.8 kb versus approximately 2.6 kb; Figures 5A and S7K ), as we observe that longer transcripts transfer less efficiently than shorter transcripts using our northern blotting protocol. Figure S5E ). Also consistently, the COX20 TE decreased more dramatically with DTT treatment than with Tm treatment ( Figure 5D ). We concluded that COX20 is a LUTI target of Hac1, with protein levels that are downregulated as part of the UPR ER .
UPR ER Activation Drives a Global Proteomic and
Metabolic Shift Why do UPR ER -activated cells couple upregulation of canonical targets, like KAR2, with downregulation of non-canonical ones, like COX20? In the case of COX20, the downregulation of its protein level was intriguing, given its role in ETC function. The UPR ER in flies has been associated with induction of glycolytic enzymes and a cell-type specific metabolic shift to increased glycolytic flux (Lee et al., 2015) . A similar shift from aerobic respiration to glycolysis is commonly observed in cancer cells and termed the ''Warburg effect'' in that context (Warburg, 1956) . We sought to determine whether such an effect might be a core part of the Hac1-dependent UPR ER by using additional global measurements in our AID-HAC1 system. First, we performed metabolomic profiling, comparing cells with and without UPR ER activation by Tm, and with and without Hac1 depletion. Of all glycolysis and tricarboxylic acid (TCA) intermediates measured, most did not change in a statistically significant manner in our experiment. Several did, however, and we noted that the two TCA intermediates (citrate and malate) that changed significantly between Hac1-containing and -depleted cells were lower in Tm-treated cells containing Hac1 than with its levels depleted, potentially suggesting reduced respiration in Hac1-containing UPR ERactivated cells ( Figure S6A ). Glycolysis-associated metabolites tended to either remain roughly constant or be higher in UPR ER -activated cells containing Hac1 ( Figure S6A ). These results were subtle and, while consistent with a shift from respiration in Hac1-containing UPR ER -activated cells, did not provide definitive proof due to our inability to detect statistically significant shifts in many relevant intermediates with and without TIR1. We hypothesized that this may have resulted from the dampened range of effects that we note above in Hac1-depletion experiments compared with those using WT versus hac1D cells. Indeed, similar analyses in cells carrying HAC1 showed consistent, significant disenrichment of TCA intermediates and enrichment of glycolytic intermediates with Tm treatment ( Figure 6A ).
To more comprehensively determine the degree to which UPR ER activation may couple downregulation of specific physiological cellular processes, such as aerobic respiration, to upregulation of classic UPR ER targets such as ER chaperones, we performed proteomic measurements in samples identical to those measured for mRNA and translation ( Figures 4A-4C and S4). We used tandem mass tag (TMT)-based isobaric labeling to compare shifts in proteome composition with and without Hac1 depletion, and with and without UPR ER activation. This experiment yielded a deep dataset, allowing comparison of the levels of 2,577 proteins with and without DTT and Hac1 (Figure 6B) . The data were of high quality, revealing the expected patterns for Hnt1, Cox20, and canonical UPR ER targets (Figure S6B) . A broad view of the data revealed dramatic overall shifts in proteome composition with DTT addition, with a subset of these changes dependent on Hac1. A discrete cluster of 72 proteins, which included canonical targets Kar2, Ero1, Pdi1, and Lhs1, emerged as increased in a UPR ER -and Hac1-dependent manner. Gene ontology (GO) analysis of the genes encoding these proteins ( Figure 6B and Table S3) showed that they were strongly enriched for roles in protein transport and ER function. A second cluster of 197 proteins showed increased protein expression following UPR ER activation that was delayed following Hac1 depletion. GO analysis of the genes encoding them revealed strong enrichment for proteolysis functions and the ER-associated degradation (ERAD) pathway ( Figure 6B and Table S4 ; consistent with Travers et al., 2000) . A third cluster of 282 proteins showed decreased protein levels with UPR ER activation, with at least partial dependence on Hac1. The associated genes were heavily enriched for roles in translation and ribosome assembly ( Figure 6B and Table S5 ). This observation is interesting, as the downregulation of translation is a welldefined aspect of the UPR ER in higher eukaryotes (Walter and Ron, 2011) . This effect has thus far been less clear in budding yeast studies, and our results suggest that it warrants revisiting. Most interestingly, given the Hac1-dependent LUTI regulation seen for Cox20 and our hypothesis that metabolism shifts away from respiration in UPR ER -activated cells, the genes encoding the group of UPR ER -dependent downregulated proteins was also enriched for roles in ATP synthesis coupled electron transport, oxidative phosphorylation, the ETC, cytochrome complexes, and the mitochondrial respiratory chain (Table S5) . KEGG pathway analysis also revealed enrichment for components of the ETC and aerobic respiration (p = 0.0027) among these downregulated genes, further supporting a metabolic shift away from aerobic respiration as part of the UPR ER . Finally, isolation of data for glycolytic enzymes revealed a complementary upregulation of protein levels that was dependent on UPR ER activation, although only some of these increases were dependent on Hac1 ( Figure S6C ).
Because TMT-based measurements often yield values that appear dampened in range relative to other methods (Wenger et al., 2011) , we also used label-free quantification (LFQ), an orthogonal approach, on the same samples. This allowed for better determination of the degree of specific protein level changes following UPR ER activation. LFQ analysis revealed trends that mirrored those seen with TMT-based quantification, but that were less muted in degree ( Figures S6B and S6D ). As expected, UPR ER induction still showed increased levels of canonical UPR ER target proteins, such as Kar2 ( Figure 6C ).
Untagged Hnt1 protein levels were dramatically reduced in a Hac1-dependent manner, to an even greater degree than observed for the epitope-tagged protein. The degree of Hnt1 decrease in Hac1-containing cells relative to cells depleted for Hac1 was roughly equivalent to the degree of Kar2 increase ( Figure S6D ), suggesting potential for a strong cellular effect from the Hac1-dependent induction of HNT1 LUTI . Cox20 showed a 2.4-fold decrease in UPR ER -activated cells containing
Hac1 compared with those depleted for it ( Figure S6D ), which was similar to the decrease observed for the epitope-tagged protein ( Figures 5G-5J ) and which suggests potential for a strong physiological effect.
Preventing Aerobic Respiration Ameliorates Cellular Growth Defects due to UPR ER Activation
Oxygen consumption assays revealed a time-dependent, significant decrease in oxygen consumption rates (OCR) of cells treated with Tm ( Figure 6D ), consistent with a decrease in aerobic respiration in UPR ER -activated cells. To investigate a potential functional role for downregulated aerobic respiration in the UPR ER , we leveraged the fact that budding yeast cells can grow well in rich media in the absence of aerobic respiration resulting from mutation in ETC-related genes. We examined cells deleted for PET100, a gene that is required for assembly of ETC complex IV (Church et al., 1996) . We compared cell doubling of untreated WT and pet100D cells in rich media, observing the expected moderate growth defect in the latter background (Figure 6E) . We then repeated the experiment in the presence of DTT and observed that, while both WT and pet100D cells doubled more slowly than in untreated conditions, the previously observed growth defect in pet100D cells relative to WT was strongly suppressed ( Figure 6F ). In fact, under these conditions, pet100D cells robustly surpassed WT cells in their growth rate. Because of possible confounding effects of using a strong reducing agent like DTT for these experiments, we performed a similar analysis instead activating the UPR ER by Tm addition, which is stable enough for use in plate-based growth assays, in contrast to DTT. Cell growth following dilution on plates containing 0-0.75 mg/mL Tm produced results similar to the DTT growth rate data ( Figure 6G ). WT cells formed larger colonies than pet100D cells without Tm, but with increasing Tm concentration, pet100D cells were able to surpass WT in growth ability. Based on these experiments, we concluded that downregulation of factors responsible for aerobic respiration, which accompanies UPR ER activation and is partially modulated by Hac1 activity, is likely to be a functionally important component of the UPR ER in yeast.
DISCUSSION
Here we report that, in addition to its characterized role in the induction of ER-related target genes during the UPR ER , Hac1 also downregulates a set of genes by driving production of mRNAs that ultimately result in reduced protein levels. Hac1 thus coordinates up-and downregulation of distinct targets, contributing to a shift in the proteome and metabolism of UPR ER -activated cells ( Figure 6H ). We report that Hac1-dependent transcription results in downregulation of at least 15 genes during the UPR ER (Table 1) . More broadly, our study provides a set of new examples of LUTI-based regulation, a recently defined mode of gene regulatory control that pervasively shapes the proteome of budding yeast cells during the meiotic program Tresenrider and Ü nal, 2018) . The fact that this regulation can be mediated by the conserved TF Hac1 as part of a conserved stress response suggests that it may be broadly used in transcriptional regulatory responses. A key component of LUTI-based regulation is cis-silencing of the proximal TSS . While transcriptional interference is well-established (e.g., Cullen et al., 1984; Martens et al., 2004) , LUTI-based regulation involves production of an interfering transcript containing a coding region that is translationally repressed. The ultimate effect of this regulation is counterintuitive from a classical gene regulatory perspective, as it involves mRNA-inducing TFs acting effectively as repressors of gene expression and results in an uncoupling of overall mRNA and protein synthesis levels due to a greater importance of the isoform type than overall transcript levels in directing protein synthesis Cheng et al., 2018) . This can be seen in the Hac1 LUTI cases defined here, including HNT1, which was previously reported to be an upregulated UPR ER target based on Hac1-dependent mRNA accumulation in response to UPR ER activation . Consistently, we find that the total mRNA abundance for HNT1 is increased during the UPR ER , dependent on Hac1. However, expression of the Hac1-dependent LUTI transcript that accounts for this mRNA increase results in decreased protein production. Due to their relative ease of measurement, mRNA abundance values have been widely used as a proxy for gene expression output. While these measurements are undoubtedly useful and may accurately predict protein level changes in many instances, they can also be misleading. HNT1 is a prime example of this in the simple and well-defined cellular response explored here. It is likely that many other existing gene expression datasets hold such examples, which may lead to misinterpretation of the cellular consequences of transcriptional responses. While cases like HNT1 are particularly striking, an overall mRNA increase is not necessarily seen in cases of LUTI production. Most of the new cases identified here instead exhibit a shift in the type of mRNA made without dramatically altering total mRNA quantity for a given gene. In these cases, mRNA levels are uninformative unless this information is integrated with translation data, and ideally measurements of protein, the ultimate gene expression output. Our use of integrated measurements from matched extract enabled a view of the UPR ER gene expression program that would have been impossible to gain from analysis of existing gene expression datasets. For example, matched protein measurements in our study were key to showing that this unconventional mechanism has a cellular effect. Our protein data, which shows decreases in levels of LUTI-regulated proteins within 1-2 hr of UPR ER activation, argue that active degradation of existing protein pools is likely also occurring under our experimental conditions, although we do not yet know the mechanism for the proteins explored here. Similarly, for this mechanism to be effective, transcript half-lives must be relatively short. While transcript destabilization is actively achieved during periods of UPR ER activation for a subset of ER-localized mRNAs by regulated Ire1-dependent decay in some organisms (Hollien et al., 2009; reviewed in Maurel et al., 2014) , this mechanism has not been observed in budding yeast. A recent study, however, reports mRNA half-lives in budding yeast to be much shorter than previously thought (Chan et al., 2017) , suggesting that an additional mechanism for degradation of canonical transcripts of LUTI-regulated genes may not be required for this regulation to be rapid and effective. Our study is not the first to suggest that the UPR ER may directly or indirectly result in translational downregulation of a set of genes. Several studies have investigated this possibility and reanalysis of their data, in light of our LUTI model and complementary measurements, reveals results consistent with our findings. For example, microarray analyses of polysome fractions with and without DTT treatment showed that ribosome biogenesis genes were translationally repressed in a DTTdependent manner, while canonical targets, such as ERO1, were well translated under these conditions (Payne et al., 2008) . Interestingly, 10 of the 15 Hac1 LUTI targets that we annotate here-including HNT1 and COX20-were among the genes detected in that study to show a DTT-dependent shift from polysomes to a sub-polysome fraction, indicating translational repression (Table 1) . More recently, mRNA-seq and ribosome profiling was reported from cells with and without Tm treatment (Labunskyy et al., 2014) . This study concluded that genes that were upregulated in response to Tm-driven UPR ER activation tended to be transcriptional targets of Hac1 and that downregulated targets tended to be regulated at the level of TE (Labunskyy et al., 2014) . This is consistent with our finding that Hac1 acts as a transcriptional activator for canonical targets and indirectly acts as a translational repressor for LUTI targets. Intriguingly, the Tm-dependent translationally downregulated genes in this previous ribosome profiling study were enriched for roles in ATP metabolic processes (p = 0.026) and mitochondria (p = 0.030), and several ETC-related genes were in this set, including two that are required for complex IV assembly (Table S6 ; Labunskyy et al., 2014) . Although their results are consistent with our data, neither of these previous studies included strains deleted or depleted for HAC1, so the degree to which effects were dependent on Hac1 was unclear, and the lack of transcript isoform data available precludes reanalysis for other features of LUTI-based regulation. Our study reveals two separate but linked key findings: the existence of Hac1-dependent LUTI-based regulation and Figure S6 and Tables S3, S4, S5, and S6. coordinated up-and downshifting of levels of distinct protein groups during the UPR ER . We propose, based on examples such as COX20, that the downregulation of genes involved in aerobic respiration observed during the UPR ER is at least partially mediated by Hac1-based induction of repressive mRNA isoforms. However, we do not find evidence that all respiratory protein downregulation is dependent on this mechanism. For most of the ETC proteins that we measured to be reduced during UPR ER activation, no associated alternative transcript isoforms were observed. This could be a result of the challenges in predicting alternative transcript isoforms based on mRNA-seq data alone, as we did in this study as a necessity, but it seems unlikely that LUTI-based regulation can directly explain the downregulation of all proteins observed here to decrease during the UPR ER . It is more likely that either a few LUTI-regulated genes act as linchpin components that cause remaining complex members to become unstable or that there are parallel, potentially synergistic mechanisms to decrease levels of respiratory proteins during the UPR ER . The cellular consequence of our newly identified cases of Hac1-dependent, LUTI-based gene repression is another outstanding question. We note an apparent enrichment for ETC function among the group, but have not identified enough cases to confidently assay statistical significance for LUTI-based regulation for this or other processes. It is likely, however, that ETC regulation is not the function of all newly proposed Hac1 LUTI mRNAs. Although several of the 15 genes encode mitochondrial proteins, most do not. Additionally, some of these genes, including HNT1, have such poorly defined cellular roles that determining the possible importance of their downregulation during the UPR ER is difficult at this time. Our proteomic data suggest a reallocation of cellular resources in UPR ER -activated cells from ribosome biogenesis to ER function, and away from respiration. It is not surprising that a stress response would require a shift in proteome content, but in this case it is unclear why the Warburg-like shift in ATPgeneration mode would bolster cellular fitness during the UPR ER ( Figure 6 ; Lee et al., 2015) . Nonetheless, our results show that such a shift occurs and is advantageous, as cells without the ability to respire show a growth advantage relative to WT cells when grown in UPR ER -activating conditions. While this result suggests that this shift is a relevant functional component of the UPR ER , it does not explain why this is the case. It has been proposed that reduction of TCA cycle activity associated with the Warburg effect seen in cancer cells allows acetyl-coenzyme A to be shunted toward the robust new lipid synthesis required for membrane expansion that accompanies rapid cell division (Vander Heiden et al., 2009) . A similar explanation is enticing in this case, as one of the hallmarks of UPR ER activation is an increase in ER membrane volume, which requires new lipid synthesis and membrane expansion. It is alternatively possible that it is important to downregulate an alternative ETC function for the UPR ER . For example, it has recently been shown that the redox function of the ETC through NAD + recycling is responsible for the growth defect seen in ETC-deficient mammalian cells (Titov et al., 2016) .
Why do UPR ER -activated cells employ the LUTI mechanism for downregulation of a subset of targets? In principle, a transcriptional repressor that is linked to UPR ER activation should allow a similar overall effect, although to our knowledge no such regulator has been identified. We argue, however, that LUTI-based regulation is as effective as this alternative classical mode of regulation. We note that several Hac1-dependent LUTI target proteins, including Cox20 and Som1, show robust upregulation in response to DTT in the absence of Hac1. Hac1-dependent induction of the LUTI transcript in these cases appears effective at preventing and even reversing these protein level increases. Furthermore, this modular mechanism of regulation allows cells to use pre-existing trans factors for both up-and downregulation of targets, precluding the need for an additional protein to act as a dedicated transcriptional repressor Cheng et al., 2018) . Perhaps most importantly, a major advantage of this mechanism is that the use of a single TF-Hac1 in this case-allows for direct coordination of upregulation of some genes with downregulation of others . This type of coordination is an attractive strategy for mediating rapid cellular responses to acute stress. The fact that a well-studied, conserved stress response program employs this unconventional mode of gene regulation suggests that LUTI-based regulation may be broadly used to modulate gene expression in contexts of cellular state change. Construction of new, integrated datasets aimed at identifying such regulation, along with revisiting traditional conceptual models of gene expression, will be required to ultimately determine whether this is the case.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS Yeast Strain Construction
All experiments were performed using Saccharomyces cerevisiae strains of the SK1 background.
Gene Deletion Strains
Deletions were created by one-step gene deletion, as described in (Longtine et al., 1998) .
AID-HAC1 Strain
Construction of this strain required deleting endogenous HAC1 and replacing it ectopically with an auxin-inducible degron (AID)-tagged version. We ensured that the promoter, intron, and UTRs, which are all required for proper regulation of HAC1, were not disrupted in this construct [ Figure 3A ; (Aragó n et al., 2009; Bowring and Llewellyn, 2001; Ogawa and Mori, 2004; Sathe et al., 2015) ]. To build the allele, we cloned 507bp upstream of the HAC1 ORF in front of a 3V5 tag, followed by the IAA7 degron, the HAC1 ORF, and 844bp downstream of the HAC1 stop codon. The entire construct was cloned into a LEU2 integrating vector (resulting in plasmid pÜ B1073) and the AflII (NEB) digestion product was subsequently transformed into a strain heterozygous for hac1D. Following sporulation, haploids were chosen that carried the AID-HAC1 allele as their sole source of Hac1. HNT1-3V5 and COX20-3V5 Strains A c-terminal 3V5 tag, marked by a G418 resistance cassette, was integrated into the endogenous locus, replacing the stop codon.
GFP Reporter Strains
For pHNT1-GFP, pHNT1 (-600 to +42) was cloned ahead of a ubiquitin-GFP fusion, followed by the Candida albicans ADH1 terminator, resulting in pÜ B1397. For pHNT1DUPRE2-GFP, the first five of the six bp in the UPRE2 motif starting at -284 were deleted from pÜ B1397 via Q5 mutagenesis, resulting in pÜ B1406. Constructs were integrated at the TRP1 locus via transformation with the PmeI (NEB) digestion product of the relevant plasmid.
Yeast Growth Conditions
Strains were grown in YEPD(2%) at 30C, with shaking. Plate-based growth assays were carried out on YEPD(4%) plates at 30C.
METHOD DETAILS Sample Collection for Sequencing Experiments WT/ hac1D
BrÜ n 1362 (WT) and 4431(hac1D) were inoculated into YEPD and grown at 30C overnight, then diluted to OD 600 0.05 in YEPD. After approximately 2 doublings, cultures were split into 3 subcultures. Per strain, a first subculture received no treatment, a second was treated with 5mM DTT, and a third was treated with 2mg/mL Tm (Calbiochem). After 1 hr, 500 mL samples were collected as in (Brar et al., 2012) , using 30 sec cycloheximide treatment, filtration, and flash freezing (in 2 portions -$90% for ribosome profiling and $10% for mRNA-sequencing). 2mL flash frozen buffer (20mM TRIS pH8, 140mM KCl, 1.5mM MgCl 2, 100mg/mL cycloheximide, 1% Triton X-100) was added to each ribosome profiling aliquot. Samples were lysed via Retsch mixermilling (6X 3 min, 15 Hz).
Resulting powder was thawed and spun at 4C for 5 min, 3,000 x g. Supernatant was removed and cleared at 4C for 10 min, 20,000 x g.
AID-HAC1
BrÜ n 10532 (AID-HAC1 -TIR1) and 10744(AID-HAC1 +TIR1) were inoculated into YEPD and grown at 30C overnight, then diluted to OD 600 0.05 in YEPD. After approximately 2 doublings, cultures were split into 2 subcultures. Per strain, one subculture was treated with 500mM auxin (Sigma) and 4mM IP 6 (Sigma) and the other with equivalent volumes of DMSO and water. After 15 min, the subcultures treated with auxin and IP6 were further split into 2 subcultures. Per strain, 1 auxin-pre-treated culture was not treated further (+auxin), and 1 was treated with 5mM DTT (+auxin +DTT). For each strain, the DMSO pre-treated subculture was treated with 5mM DTT (+DTT +vehicle). After 1 hr, 500 mL per culture was harvested identically as in the WT/hac1D experiment, except the buffer was supplemented with 2mg/mL Aprotinin (Sigma), 10mg/mL Leupeptin (Sigma), 1 mM PMSF (Sigma), 1:100 PIC2 (Sigma), and 1:100 PIC3 (Sigma). After 1 additional hr, a second 500 mL sample was harvested from each culture. Extract was prepared as in the WT/hac1D experiment, and identical extract was used for ribosome profiling and mass spectrometry.
Additional Sample Collection for Protein/RNA WT/hac1D Transcript Comparisons One biological replicate was derived from total RNA prepared for the sequencing experiment described above. An additional replicate was collected similarly, except was harvested by filtration without the addition of cycloheximide.
WT/ ire1D Transcript Comparisons
Two biological replicates were collected as follows. BrÜ n 15 (WT) and 15924 (ire1D) were inoculated into YEPD and grown at 30C overnight, then diluted to OD 600 0.05 in YEPD. After approximately 2 doublings, cultures were split into 3 subcultures. Per strain, a first subculture received no treatment, a second was treated with 5mM DTT, and a third was treated with 2mg/mL Tm (Calbiochem). Samples were harvested at the indicated times by filtration.
Additional AID-HAC1 Transcript Comparisons
For cases where cells were pre-treated with auxin and subsequently treated with DTT, one biological replicate was derived from total RNA prepared for the sequencing experiment above. An additional replicate was collected similarly, except was directly harvested by filtration without the addition of cycloheximide. For analysis of AID-Hac1 protein levels in these experiments, 3 biological replicates were collected similarly except 2.5 OD units were harvested at each time point and treated with 5% trichloroacetic acid (TCA).
For cases where cells were pre-treated with DTT and subsequently treated with auxin, 2 biological replicates were collected as follows. BrÜ n 10532 (AID-HAC1 -TIR1) and 10744(AID-HAC1 +TIR1) were inoculated into YEPD and grown at 30C overnight, then diluted to OD 600 0.05 in YEPD. After approximately 2 doublings, the BrÜ n 10744 culture was split into 2 subcultures. BrÜ n 10532 and one of the BrÜ n 10744 subcultures were treated with 5 mM DTT, while the other BrÜ n 10744 subculture remained untreated. After 45 min, samples from each culture were collected by filtration. Both DTT-treated cultures were then treated with 500mM auxin (Sigma) and 4mM IP 6 (Sigma/Santa Cruz Biotechnology), while the untreated culture was treated with DMSO. Additional samples were collected by filtration at the indicated times. For analysis of Kar2 protein levels in these experiments, 3 biological replicates were collected similarly except 2.5 OD units were harvested at each time point and treated with 5% TCA. Evaluation of HNT1 and COX20 Expression For evaluation of Hnt1 and Cox20 protein levels upon DTT or Tm treatment ( Figures 2G, 2I , 5G, 5I), BrÜ n 10778 (HNT1-3V5) and 10781 (COX20-3V5) were harvested as follows. The appropriate strain was inoculated into YEPD and grown at 30C overnight, then diluted to OD 600 0.05 in YEPD. After $2 doublings, 2.5 OD units were collected and treated with 5% TCA, and cultures were subsequently treated with either DTT or Tm. Additional samples (2.5 OD units each time) were taken at the indicated times. Three full biological replicates were harvested for each condition. For similar experiments in the AID-HAC1 background, BrÜ n 10924 and 10925 were used for Hnt1 analysis, and BrÜ n 10929 and 11133 were used for Cox20 analysis. Collection was the same, except that cultures were pre-treated for 15 min with 500mM auxin (Sigma) and 4mM IP 6 (Sigma) prior to initial sample collection and 5mM DTT treatment. Additionally, approximately 20mL per culture was collected at each time point and used for downstream RNA applications.
Evaluation of GFP Reporter Expression
For evaluation of GFP transcript levels, BrÜ n 15968 (pHNT1-GFP) and 16374 (pHNT1DUPRE2-GFP) were inoculated into YEPD and grown at 30C overnight, then diluted to OD 600 0.05 in YEPD. After $2 doublings, cultures were treated with 5mM DTT. Following 90 min treatment, samples were harvested by filtration and flash-frozen for total RNA isolation. Two biological replicates were harvested for each condition.
For evaluation of GFP protein levels ( Figure 2M ), BrÜ n 15968 (pHNT1-GFP) and 16374 (pHNT1DUPRE2-GFP) were inoculated into YEPD and grown at 30C overnight, then diluted to OD 600 0.05 in YEPD. After $2 doublings, 2.5 OD units were collected and treated with 5% TCA, and cultures were subsequently treated with 5mM DTT. Additional samples (2.5 OD units each time) were taken at the indicated times. Three biological replicates were harvested for each condition.
Growth Curves
For Figure 3B , growth curve was performed as follows: BrÜ n 13 (WT), BrÜ n 4431 (hac1D), and BrÜ n 10353 (AID-HAC1) were inoculated into YEPD and grown at 30C overnight, then diluted to OD 600 0.05 in YEPD. After 7 hr, cultures were back-diluted to OD 600 0.15 in YEPD. In a 96-well plate, 150mL cells were treated in triplicate with 2.5mM DTT. Cultures were grown overnight in a 30C, shaking plate reader (Tecan Infinite M1000), with absorbance at 600nm measurements taken every 15 min. Absorbance readings in Figure 3B represent averaged values across triplicate wells.
For Figures 6E and 6F , growth curves were performed as follows: BrÜ n 15 (WT) and BrÜ n 2781 (pet100D) were inoculated into YEPD and grown at 30C overnight, then diluted to OD 600 0.05. After $2 doublings, cultures were split into 2 subcultures, one of which remained untreated and one of which was treated with 5mM DTT. OD 600 readings were taken every hr. OD 600 values in Figures 6E and  6F are normalized to the exact OD 600 reading just before treatment and represent average fold change from starting OD 600 across 3 biological replicates.
Plate-Based Growth Assays
BrÜ n 15 (WT) and BrÜ n 2781(pet100D) were inoculated into YEPD and grown at 30C overnight, then diluted to OD 600 0.2 in YEPD. Approximately 4.5 hr later, cultures were diluted to OD 600 0.1 in water. Samples were briefly sonicated to prevent clumping, and 5-fold dilutions were prepared in water. 3 mL of each dilution were plated on YEPD (4%) containing 0mg, 0.5mg or 0.75mg/mL Tm. Plates were imaged after 2 nights at 30C.
Northern Blotting
All RNA was isolated using the hot acid phenol method. 8-10mg of total RNA was denatured in glyoxal mix [1M glyoxal (Sigma), 50% DMSO, 10mM NaPO 4 pH 6.8] for 10 min at 70C. Denatured samples were loaded onto a 1.1% agarose gel, separated at 116V for 3 hr, and transferred overnight to a nylon membrane [Hybond-N+ (GE)]. Following UV crosslinking and methylene blue staining, the membrane was blocked at 68C for at least 45 min with Ultrahyb buffer (Invitrogen) supplemented with boiled sonicated salmon sperm DNA (Agilent). All probe templates were generated by PCR (primers in Table S7 ) of WT yeast genomic DNA, except the GFP probe template, which was generated by amplification from a GFP-containing plasmid. The probe was in vitro transcribed [MaxiScript T7 Kit (Invitrogen)] using all kit components, except cold UTP was replaced with alpha-P32 labeled UTP (PerkinElmer). The blot was incubated with the hot probe at 68C overnight, and subsequently washed for 2X 5 min at RT with low stringency wash buffer (2X SSC, 0.1% SDS) and 2X 15 min at 68C with high stringency wash buffer (0.1X SSC, 0.1% SDS). Typhoon phosphor-imaging was used for visualization. For each transcript probed, at least 2 biological replicates were performed and sizing was confirmed on a sample blot with ladders ( Figures S7E-S7G ) and, more routinely, by comparison to rRNA bands. In our experience, likely due to their highly stable structural features, rRNA (2.0 kB and 3.8 kB) species tend to migrate slightly faster than would be expected for mRNAs (for example, Figures S7I and S7J ), making all of our size comparisons approximate.
replicates were collected per condition. For Figure 6A , BrÜ n 15 (WT) was used, except without the addition of auxin/IP6 and 6 technical replicates were collected per condition.
For both experiments, metabolomic analyses were performed as reported previously (Louie et al., 2016) . Briefly, frozen cell pellets were resuspended with 150mL 40:40:20 acetonitrile/methanol/water containing 10nmoles D 3 N 15 serine internal standard (Cambridge isotopes). Samples were vortexed thoroughly for 30 sec and bath sonicated for 15 sec before centrifugation at 21,000 x g for 10 min. Supernatant was collected and frozen at À80 C until analysis. 20 mL of supernatant was analyzed by single-reaction monitoring (SRM)-based targeted LC-MS/MS. Separation of metabolites was performed by normal-phase chromatography using a Luna-5 mm NH2 column (50 mm x 4.60 mm, Phenomenex). Mobile phases were run as follows: Buffer A, acetonitrile; Buffer B, 95:5 water/ acetonitrile with 0.1% formic acid or 0.2% ammonium hydroxide with 50 mM ammonium acetate for positive and negative ionization modes, respectively. Flow rate began at 0.2 mL/min for 2 min, followed by a gradient starting at 0% B and increasing linearly to 100% B over the course of 13 min with a flow rate of 0.7 mL/min, followed by an isocratic gradient of 100% B for 10 min with a flow rate of 0.7mL/min before equilibrating for 5 min at 0% B with a flow rate of 0.7 mL/min. MS analysis was performed using an electrospray ionization (ESI) source on an Agilent 6430 QQQ LC-MS/MS. Capillary voltage was 3.0 kV, fragmentor voltage was 100 V, drying gas temperature 350 C, drying gas flow rate was 10 L/min, and the nebulizer pressure was 35 psi. Representative metabolites were quantified by SRM of the transitions from precursor to product ions at associated collision energies. Data was analyzed by calculating area under the curve using Agilent Qualitative Analysis software.
Oxygen Consumption Assay
Except for materials needed for yeast cultures, all steps were carried out using components from a Seahorse Extracellular FluxPak (Agilent). Preparation of Cartridge A Seahorse Extracellular Flux cartridge was hydrated with 200ml water per well overnight at 30C. Approximately 90 min prior to taking basal OCR measurements, water was removed and replaced with 200ml pre-warmed XF Calibrant solution. Preparation of Cell Culture Plate Wells were coated with 20ml 0.1mg/mL poly-L-lysine (Sigma) for 10 min at RT. Poly-L-lysine was then removed and the plate allowed to dry before adding cells. Cells were grown and plated as follows. BrÜ n 15 (WT) was inoculated into YEPD and grown at 30C overnight, then diluted to OD 600 0.05 in YEPD. After $2 doublings, cells were treated with 2mg/mL Tm (Calbiochem). This culture was used for the 6.5 hr Tm treatment samples. After 4.5 hr, an additional OD 600 0.05 culture was started from the overnight inoculation, and after $2 doublings, cells were treated with 2mg/mL Tm (Calbiochem) or vehicle. These cultures were used for the 2 hr Tm treatment samples and the control samples, respectively. After 6 hr and 1.5 hr, respectively, 0.3 OD units centrifuged at 1,500 x g, 2 min, RT. Cells were resuspended in 2 mL and then diluted 1:6 in fresh media (supplemented with Tm as appropriate). 180ul was added to each of 12 wells per condition. The plate was spun at 500 x g for 3 min at RT and then placed at 30C for 30 min. Immediately before OCR measurements, the plate was spun again as before.
OCR Measurements
Following initial calibration, basal OCR was measured using a 2 min mix, 2 min measure protocol. Measurements, normalized to OD at the end of the assay, are reported in Figure 6D .
Mass Spectrometry TMT-Labeling and Sample Fractionation
Proteins were precipitated by adding À20 C cold acetone to the lysate (acetone to eluate ratio 10:1) and overnight incubation at À20 C. The proteins were pelleted by centrifugation at 20000xg for 15 min at 4 C. The supernatant was discarded and the pellet was left to dry by evaporation. The protein pellet was reconstituted in 100ml urea buffer (8M Urea, 75mM NaCl, 50mM Tris/HCl pH 8.0, 1mM EDTA), and protein concentrations were determined by BCA assay (Pierce). Fifteen mg of total protein per sample were processed further. Disulfide bonds were reduced with 5mM DTT and cysteines were subsequently alkylated with 10mM iodoacetamide. Samples were diluted 1:4 with 50mM Tris/HCl (pH 8.0) and sequencing grade modified trypsin (Promega) was added in an enzyme-to-substrate ratio of 1:50. After 16hr of digestion, samples were acidified with 1% formic acid (final concentration). Tryptic peptides were desalted on C18 StageTips according to (Rappsilber et al., 2007) and evaporated to dryness in a vacuum concentrator. Desalted peptides were labeled with the TMT11plex mass tag labeling reagent according to the manufacturer's instructions (Thermo Scientific) with small modifications. Briefly, 0.2units of TMT10plex reagent was used per 15mg of sample. Peptides were dissolved in 30ml of 50mM Hepes pH 8.5 solution and the TMT10plex reagent was added in 12.3ml of MeCN. After 1hr incubation, the reaction was stopped with 2.5ml 5% Hydroxylamine for 15min at 25 C. Differentially labeled peptides were mixed for each replicate (A-L were labeled with 126C, 127N, 127C, 128N, 128C, 129N, 129C, 130N, 130C, 131N , 131C, respectively) and subsequently desalted on C18 StageTips (Rappsilber et al., 2007) and evaporated to dryness in a vacuum concentrator.
The peptide mixtures were fractionated by Strong Cation Exchange (SCX) using StageTips as previously described (Rappsilber et al., 2007) with slight modifications. Briefly, one StageTip was prepared per sample by three SCX discs (3M, #2251) topped with two C18 discs (3M, #2215). The packed StageTips were first washed with 100ml methanol and then with 100ml 80% acetonitrile and 0.2% formic acid. Afterwards, they were equilibrated by 100ml 0.2% formic acid and the sample was loaded onto the discs. The sample was transeluted from the C18 discs to the SCX discs by applying 100ml 80% acetonitrile; 0.2% formic acid, which was followed by 3 stepwise elutions and collections of the peptide mix from the SCX discs. The first fraction was eluted QUANTIFICATION AND STATISTICAL ANALYSES Sequence Alignments and Analysis Performed as described in , we observed the high technical and biological reproducibility that our lab typically observes using ribosome profiling and mRNA-sequencing. Plots are provided ( Figure S7 ) that exemplify this reproducibility. In the cases analyzed, we compared samples that should be biologically similar and that were harvested to provide additional controls within the experiment presented in Figure 4A . Alignments were done using bowtie2 (Langmead and Salzberg, 2012) . Genome browser analysis was done using Mochiview (Homann and Johnson, 2010) . Cluster analysis and visualization were done using Cluster 3.0 and Java Treeview, respectively (De Hoon et al., 2004; Saldanha, 2004) .
LUTI Identification mRNA-seq and ribosome profiling data for WT and hac1D cells, with either no treatment or treatment with DTT or Tm, as described above, were analyzed by genome browser (Mochiview). All annotated yeast genes were inspected visually for evidence of an alternate, 5 0 extended transcript with translated uORFs that was Hac1-and UPR ER -dependent. This approach was enabled by the simple transcript structures of most budding yeast genes. Of the $30 candidates found by this approach, 19 showed an associated Hac1-dependent decrease in TE and were defined as candidate LUTIs. This set of 19 was reevaluated one-by-one in the AID-Hac1 experiment to determine if these hallmarks remained strong. In 15 cases, this was true, and these genes are presented in Table 1 . Note that a major caveat of this approach is that it is biased towards analysis of highly expressed mRNAs, as it is much more straightforward in these cases to detect the robust presence of alternate transcripts.
Translation Efficiency Calculations
TE values were obtained as described in (Ingolia et al., 2009) . We calculated TE by dividing unfiltered footprint RPKMs by unfiltered mRNA RPKMs, summing reads over each annotated canonical ORF.
